Experimental techniques that aim to reprogram glial cells into neurons or stimulate latent axonal growth pathways have yielded promising results in preclinical models
So you can't just put collagen in everything
What makes GLP-1 agonists unique is their ability to also support weight loss
If oral Wegovy proves to be commercially successful and Novo Nordisk can demonstrate even small achievements in its pipeline, investors may reevaluate the company from ex-growth GLP1 incumbent to multi-format obesity platform firm, which is the type of narrative that can warrant a 2x increase over several years
M., Westenbroek, R., Pellerin, L
Mistake #7: Not Tracking What Works and What Doesn't Why it's wrong: By day 7, you won't remember what made you feel good versus what made you feel terrible